FDA Finalizes Labeling Rule As Pre-emption Battle At Supreme Court Looms
This article was originally published in The Pink Sheet Daily
Executive Summary
January’s proposed rule remains mostly unchanged, but the definition of “newly acquired information” is slightly broader now.
You may also be interested in...
Pre-emption Rule Delays Safety-related Label Changes, Waxman Charges
An FDA rule that requires the agency to approve labeling changes before they can be made has delayed the addition of safety information to at least two products, according to a report from Rep. Henry Waxman, D-Calif
Drug Industry Braces For Supreme Court Ruling In Wyeth Pre-emption Case
This week everyone's attention is riveted on the presidential election. But for the pharmaceutical industry there is another issue just as compelling. On Nov. 3, the U.S. Supreme Court will hear oral arguments in the case that will decide the future of product liability litigation
Pre-emption Rule Delays Safety-related Label Changes, Waxman Charges
An FDA rule that requires the agency to approve labeling changes before they can be made has delayed the addition of safety information to at least two products, according to a report from Rep. Henry Waxman, D-Calif